Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.

Authors

Ali Yilmaz, Beaumont Health
Zafer Ugur, Beaumont Health
Ilyas Ustun, Beaumont Health
Sumeyya Akyol, Beaumont Health
Ray O Bahado-Singh, Beaumont Health
Michael Maddens, Beaumont Health
Jan O Aasly
Stewart F Graham, Beaumont Health

Document Type

Article

Publication Date

10-31-2020

Publication Title

Cells

Abstract

CSF from unique groups of Parkinson's disease (PD) patients was biochemically profiled to identify previously unreported metabolic pathways linked to PD pathogenesis, and novel biochemical biomarkers of the disease were characterized. Utilizing both

Volume

9

Issue

11

Recommended Citation

Yilmaz A, Ugur Z, Ustun I, Akyol S, Bahado-Singh RO, Maddens M, Aasly JO, Graham SF. Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study. Cells. 2020 Oct 31;9(11):2394. doi: 10.3390/cells9112394. PMID: 33142859; PMCID: PMC7693941.

DOI

10.3390/cells9112394

ISSN

2073-4409

PubMed ID

33142859